Tilray Shares Struggle to Hold Gains Amid Regulatory Shift

Tilray US88688T1007

The anticipated stock market celebration following a landmark U.S. policy change has failed to materialize for Tilray Brands, Inc. Investors are facing a classic case of “selling the news,” with recent gains evaporating and testing shareholder patience once more. This is occurring despite the historic rescheduling of cannabis and a significant corporate restructuring of the company’s stock.

Adding to the current pressure is a recent change to Tilray’s capital structure. On December 1, 2025, the company executed a 1-for-10 reverse stock split. This action reduced the number of outstanding shares from approximately 1.16 billion to about 116 million. Management outlined clear objectives for this move:

• Shedding the perception of Read more...